Granted Patent
B1
US 6,903,186 · App. 09/857,636 · Granted Jun 7, 2005
Analogues of GLP-1
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention is directed to peptide analogues of glucagon-like peptide-1, the pharmaceutically-acceptable salts thereof, to methods of using such analogues to treat mammals and to pharmaceutical compositions useful therefor comprising said analogues.
Claims (4)
1. A compound wherein said compound is
[Aib 8,35 ]hGLP-1(7-36)NH 2 (SEQ ID NO:2),
or a pharmaceutically acceptable salt thereof.
2. A composition comprising a compound according to claim 1 or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier or diluent.
Assignments (1)
CHANGE OF NAME
Recorded Feb 11, 2009
From: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S.
To: IPSEN PHARMA S.A.S.
Reel/Frame 022240/0332 →